Francois Vigneault, departing Shape Therapeutics CEO
October 17, 2024 01:16 PM EDT
People
Startups
Cell/Gene Tx

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

Kyle LaHucik

Senior Reporter

Shape Ther­a­peu­tics CEO Fran­cois Vi­gneault has de­part­ed the RNA gene ther­a­py start­up, and chief sci­en­tif­ic of­fi­cer David Huss is fill­ing the post while the Seat­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times